Trial Profile

Optimized treatment algorithm in early rheumatoid arthritis: methotrexate and intra-articular glucocorticosteroid plus adalimumab or placebo in the treatment of early rheumatoid arthritis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adalimumab (Primary) ; Methotrexate; Triamcinolone
Indications Rheumatoid arthritis
Focus Therapeutic Use
Acronyms OPERA

Most Recent Events

06 Jun 2020 Results of secondary analyses presented at the 21st Annual Congress of the European League Against Rheumatism
01 Jul 2018 Results of post-hoc analysis from CIMESTRA and OPERA trials published in the Scandinavian Journal of Rheumatology.
15 Nov 2017 Results published in The Journal of Rheumatology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com